BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23776529)

  • 21. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.
    Sridhar A; Khan D; Abdelaal M; Elliott JA; Naughton V; Flatt PR; Le Roux CW; Docherty NG; Moffett CR
    PLoS One; 2022; 17(9):e0274788. PubMed ID: 36137097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
    Meirelles K; Ahmed T; Culnan DM; Lynch CJ; Lang CH; Cooney RN
    Ann Surg; 2009 Feb; 249(2):277-85. PubMed ID: 19212182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
    Abegg K; Schiesser M; Lutz TA; Bueter M
    Physiol Behav; 2013 Sep; 121():70-8. PubMed ID: 23562866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric bypass in obese rats causes bone loss, vitamin D deficiency, metabolic acidosis, and elevated peptide YY.
    Canales BK; Schafer AL; Shoback DM; Carpenter TO
    Surg Obes Relat Dis; 2014; 10(5):878-84. PubMed ID: 24969093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
    Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
    Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roux-en-Y gastric bypass alters intestinal glucose transport in the obese Zucker rat.
    Meng Q; Culnan DM; Ahmed T; Sun M; Cooney RN
    Front Endocrinol (Lausanne); 2022; 13():901984. PubMed ID: 36034439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
    Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
    Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PYY/Y2R-deficient male mouse is not protected from bone loss due to Roux-en-Y gastric bypass.
    Zahedi B; Daley EJ; Brooks DJ; Bruce M; Townsend RL; Berthoud HR; Bouxsein ML; Yu EW
    Bone; 2023 Feb; 167():116608. PubMed ID: 36368466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of nutrient sensing in the metabolic changes after gastric bypass surgery.
    Steensels S; Lannoo M; Avau B; Laermans J; Vancleef L; Farré R; Verbeke K; Depoortere I
    J Endocrinol; 2017 Mar; 232(3):363-376. PubMed ID: 27980002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery.
    Shin AC; Zheng H; Townsend RL; Sigalet DL; Berthoud HR
    Endocrinology; 2010 Apr; 151(4):1588-97. PubMed ID: 20179262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.
    Pal A; Rhoads DB; Tavakkoli A
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G668-G678. PubMed ID: 30896970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PYY/Y2R-Deficient Mouse Responds Normally to High-Fat Diet and Gastric Bypass Surgery.
    Boland B; Mumphrey MB; Hao Z; Gill B; Townsend RL; Yu S; Münzberg H; Morrison CD; Trevaskis JL; Berthoud HR
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30857366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
    Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
    Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
    Nielsen S; Svane MS; Kuhre RE; Clausen TR; Kristiansen VB; Rehfeld JF; Holst JJ; Madsbad S; Bojsen-Moller KN
    Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28202805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Cavin JB; Couvelard A; Lebtahi R; Ducroc R; Arapis K; Voitellier E; Cluzeaud F; Gillard L; Hourseau M; Mikail N; Ribeiro-Parenti L; Kapel N; Marmuse JP; Bado A; Le Gall M
    Gastroenterology; 2016 Feb; 150(2):454-64.e9. PubMed ID: 26481855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats.
    Dischinger U; Heckel T; Bischler T; Hasinger J; Königsrainer M; Schmitt-Böhrer A; Otto C; Fassnacht M; Seyfried F; Hankir MK
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion.
    Martinussen C; Bojsen-Møller KN; Dirksen C; Svane MS; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3233-3244. PubMed ID: 30844053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
    Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
    Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.